Senior Associate Scientist/Scientist, Bioanalytical Sciences jobs in United States
cer-icon
Apply on Employer Site
company-logo

REGENXBIO · 1 week ago

Senior Associate Scientist/Scientist, Bioanalytical Sciences

REGENXBIO is an exceptional place to work, offering opportunities to collaborate with leading experts in gene therapy. The Scientist role involves developing and validating bioanalytical methods to support the company's gene therapy pipeline, ensuring compliance with regulatory standards and promoting innovation in analytical techniques.

BiopharmaBiotechnologyGeneticsTherapeutics

Responsibilities

Develops, qualifies and/or validates robust bioanalytical methods per Health Authority Guidance Documents using biochemical technique (qPCR, ddPCR, ligand binding assays) to support the Company pipeline
Promotes innovation and direct operational improvement and/or evaluation of new analytical techniques or technology
Troubleshoots and resolves bioanalytical method issues to successful resolution
Takes accountability and demonstrates responsibility regarding scientific study conduct
Ensures analytical development/validation activities conducted internally and with contracted services lead to robust methods that support bioanalytical analysis
Conducts technology transfer between research organization, in-house and contract laboratories
Writes and reviews study protocols, analytical procedure, reports for regulatory submissions
Performs technical reviews of analytical data and be responsible for data interpretation, analysis, and reporting of results for method development and validation
Provides scientific and technical input to the study team and other departments
Ensures that any circumstances that may affect the quality and integrity of the study are identified and documented as they occur and that appropriate corrective actions are taken
Identifies process improvement opportunities, participates in execution of initiatives
Coordinates parallel tasks across multiple projects and plans, prioritizes, and manages duties to meet departmental and organizational goals
Mentors and/or trains new and less-experienced employees and develops training materials and schedules
Reviews and participates in writing of departmental Standard Operating Procedures (SOPs)
Performs additional tasks or assist with special projects as assigned or needed
The Scientist will be required to maintain familiarity with scientific literature and apply it appropriately to projects (such as evaluating new methodologies and techniques)

Qualification

Bioanalytical methods developmentPCR techniques qPCRPCR techniques ddPCRFDA bioanalytical guidanceAssay validation dPCRAssay validation LBAAssay validation LC-MS/MSStatistical toolsSoftwareTechnical writing skillsProblem-solving abilitiesTeam-orientedCross-functional collaboration

Required

PhD in relevant scientific discipline with 1+ years of industry or post-doctoral experience or Master's degree in relevant scientific discipline with 5+ years of relevant experience
Solid understanding of polymerase chain reaction (PCR) including both qPCR and ddPCR, experience using commercially available PCR machine, and ability to design primers/probes sets
Strong knowledge of FDA and global bioanalytical assay guidance
Skilled in independently designing and executing experiments to meet project goals
Experienced in developing and validating assays (dPCR, qPCR, LBA, LC-MS/MS) and performing advanced data analysis
Proficient in interpreting results, troubleshooting, and recommending next steps
Effective communicator with strong presentation and technical writing skills
Capable of leading cross-functional and external collaborations
Team-oriented with proven problem-solving abilities
Proficient in statistical tools and software (SoftMax, MS Office)

Preferred

Industry experience preferred; gene therapy knowledge a plus
LBA and LC-MS/MS a plus

Benefits

Health, dental, and vision insurance
Retirement plan with 401(k) match
Summer hours

Company

REGENXBIO

twittertwittertwitter
company-logo
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Funding

Current Stage
Public Company
Total Funding
$928.19M
Key Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M

Leadership Team

leader-logo
Curran Simpson
President and CEO
linkedin
leader-logo
Francesca Cook
Vice President, Global Pricing and Market Access
linkedin
Company data provided by crunchbase